Inhibrx Biosciences (INBX) Shares Outstanding (Diluted) (2023 - 2025)

Inhibrx Biosciences (INBX) Shares Outstanding (Diluted) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 52.24 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - 10.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 680.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 64.41 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Inhibrx Biosciences 1.32 Bn 1.32 Bn - 15.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 15.49 Mn
Sep 30, 2025 15.48 Mn
Jun 30, 2025 15.47 Mn
Mar 31, 2025 15.47 Mn
Dec 31, 2024 14.98 Mn
Sep 30, 2024 15.47 Mn
Jun 30, 2024 14.81 Mn
Mar 31, 2024 13.64 Mn
Dec 31, 2023 11.78 Mn
Sep 30, 2023 11.79 Mn
Jun 30, 2023 10.91 Mn